Lead Product(s): TACH204
Therapeutic Area: Oncology Product Name: TACH204
Highest Development Status: Discovery Product Type: Large molecule
Partner/Sponsor/Collaborator: Tachyon Technologies
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Collaboration August 03, 2021
AbCellera is eligible to receive milestone payments and royalties on products that are derived from its antibody discovery platform. In addition, AbCellera has the option to invest in preclinical and clinical development in exchange for an increased share of product sales.